Effect of Steady-State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open-Label, Fixed-Sequence Crossover Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Steady-State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open-Label, Fixed-Sequence Crossover Study

Published:2017-05-17 Issue:10 Volume:57 Page:1305-1314
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Huang Fenglei¹^ORCID,Marzin Kristell²,Koenen Rüdiger²,Kammerer Klaus Peter³,Strelkowa Natalja²,Elgadi Mabrouk⁴,Quinson Anne-Marie¹,Haertter Sebastian¹

Affiliation:

1. Boehringer Ingelheim Pharmaceuticals; Inc.; Ridgefield CT USA

2. Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach Germany

3. Boehringer Ingelheim Pharma GmbH & Co. KG; Ingelheim Germany

4. Boehringer Ingelheim (Canada) Ltd/Ltée; Burlington Ontario Canada

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.931/fullpdf

Reference51 articles.

1. Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease;White;Antimicrob Agents Chemother,2010

2. STARTVerso1: a randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection;Ferenci;J Hepatol,2015

3. Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis;Zeuzem;Antimicrob Agents Chemother,2015

4. Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study;Zeuzem;Liver Int,2015

5. Faldaprevir and deleobuvir for HCV genotype 1 infection;Zeuzem;N Engl J Med,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-10-11

2. Influencia de la farmacogenética en la diversidad de respuesta a las estatinas asociada a las reacciones adversas;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-10-05

3. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

4. The preventive effects of different doses of atorvastatin on contrast‐induced acute kidney injury after CT perfusion;Journal of Clinical Laboratory Analysis;2022-05-17

5. Personalized medicine in lipid-modifying therapy;Personalized Medicine;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3